Phototherapy Light Unit (Double Array)
Model: HPU 0502
Overall Size: L1020mm x W520mm x H1825mm
Phototherapy is the most effective treatment for neonatal jaundice, also known as hyperbilirubinemia. Neonatal jaundice is a very common complication found among newborn infants. Though minor incidents need do not require active treatment, when severe, it can cause bilirubin encephalopathy, a condition that may lead to handicap or even death.
While monitoring a case of bilirubin in a laboratory is necessary, it is also time consuming and distressing for the baby. It may even result in severe infections.
Transfusion for severe neonatal jaundice is both tedious and expensive with high mobility and mortality rates. It is also followed by prompt and marked bilirubin rebound.
As an alternative treatment, phototherapy has now largely replaced exchange transfusion. Although the results are more gradual, phototherapy prolongs the reduction of bilirubin concentration.
The treatments efficiency is influenced by the infants gestational age, birth weight and postnatal age. In most etiologies, based on the jaundice and also the spectral emission and intensity (dose) of the light, it can control very severe cases of jaundice or a rapidly-rising bilirubin concentration, including severe hemolysis.
Its relative freedom from complications, non-invasive nature, ease of use and overall convenience have resulted in widespread acceptance and adoption in virtually all neonatal units.
The procedures double-array coverage enables comprehensive treatment, without having to physically move or disturb the infant during treatment.